Effect of Moxifloxacin-Triple Therapy Versus Clarithromycin-Triple Therapy for the Eradication of Helicobacter Pylori Infections Regarding to Age and BMI.
Helicobacter pylori (H. Pylori) is one of the most common infectious human pathogens, which infected more than (50%) of the populations worldwide. • pylori induce inflammation, which causes of upper gastrointestinal illnesses including dyspepsia, peptic ulcer diseases, gastroesop...
Main Authors: | Ahmed Mansur Kadhim, Mohammed Mahmood Mohammed, Hussein Muhammad Hassan |
---|---|
Format: | Article |
Language: | English |
Published: |
College of Pharmacy / Mustansiriyah University
2019-03-01
|
Series: | Al-Mustansiriyah Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/541 |
Similar Items
-
Treatment of Helicobacter Pylori Infections Using Moxifloxacin-Triple Therapy Compared to Standard Triple and Quadruple Therapies
by: Mohammed Mahmood Mohammed
Published: (2023-06-01) -
The Efficacy of Moxifloxacin-containing Triple Therapy after Hybrid Therapy Failure in Helicobacter pylori Eradication
by: Soohoon Kwon, et al.
Published: (2017-08-01) -
The Efficacy of Levofloxacin-Based Triple Therapy over Standard ClarithromycinBased Therapy for Eradication of Helicobacter Pylori
by: Haseeb Noor, et al.
Published: (2024-01-01) -
The Efficacy of Moxifloxacin-Containing Triple Therapy after Standard Triple, Sequential, or Concomitant Therapy Failure for Helicobacter pylori Eradication in Korea
Published: (2014-11-01) -
Comparing Clarithromycin- and Levofloxacin-Containing Triple Therapies for First Line Helicobacter pylori Eradication
in Mazandran Province, Iran
by: Sepehr Tirgar Fakheri, et al.
Published: (2019-09-01)